semaglutide and hiv New research adds to the growing body of evidence around #Semaglutide. In a randomized, placebo-controlled trial, slowed multiple epigenetic markers of biological aging in adults living with HIV. $NVO #NovoNordisk #GLP1 # Semaglutide shows promise for improving

The semaglutide shortage has officially ended in the USwhich means the GLP-1 drug industry is about to undergo massive changes.

FDA-registered 503A pharmacy

Understanding how your body processes this medication helps you and your provider make the best dosing decisions for sustainable weight loss results

At Relive Wellington, we're more than just a medical spa

Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective surgery and gastrointestinal endoscopies, according to new clinical guidance released by five surgical and medical societies including the American Society for Metabolic and Bariatric Surgery (ASMBS), American Society of Anesthesiologists (ASA), American Gastroenterological Association (AGA), International Society of Perioperative Care of Patients with Obesity (ISP

Their lead candidate, ECC5004, is an oral GLP-1 agonist licensed to AstraZeneca for global development (excluding China), while Eccogene retains co-development and co-commercialization rights in China